title: SOP 14: Population pharmacokinetic analysis.
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D054316:Biomarkers, Pharmacological / Q000032:analysis*; D001800:Blood Specimen Collection / Q000592:standards; D002986:Clinical Trials as Topic / Q000592:standards* / Q000706:statistics & numerical data*; D003196:Computer Graphics / Q000592:standards / Q000706:statistics & numerical data; D003625:Data Collection / Q000592:standards / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005060:Europe; D019983:Guideline Adherence / Q000592:standards; D006801:Humans; D008657:Metabolic Clearance Rate; D015233:Models, Statistical; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy*; D015203:Reproducibility of Results
chemical_list: D000970:Antineoplastic Agents; D054316:Biomarkers, Pharmacological; D015507:Drugs, Investigational